Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3693840014 | Podophyllotoxin 1.5 mg/g cutaneous cream | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 3693842018 | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 107772501000001111 | Podophyllotoxin 0.15% cream | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Product containing teniposide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Teniposide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Podophyllotoxin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Product containing Podophyllum resin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Podophyllum resin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Product containing podophyllotoxin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Skin agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cutaneous AND/OR transdermal dosage form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Product manufactured as cutaneous dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has precise active ingredient | Podophyllotoxin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator unit | gram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has concentration strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has concentration strength numerator value | 1.5 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has basis of strength substance | Podophyllotoxin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Product containing only podophyllotoxin in cutaneous dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Plays role | Antiviral therapeutic role | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cutaneous dose form | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has active ingredient | Podophyllotoxin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | cream.cutaneous ontology form and route | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Continuous dose form indicator | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Topical route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Cutaneous | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Conventional release cutaneous cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Podophyllotoxin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has manufactured dose form | Cream | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has specific active ingredient | Podophyllotoxin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Has dispensed dose form | Cream | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Is a | Virtual medicinal product | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Podophyllotoxin 0.15% cream - product | Is a | False | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Warticon 0.15% cream (Stiefel Laboratories Ltd) | Is a | True | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Warticon 0.15% cream (CST Pharma Ltd) | Is a | True | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Podophyllotoxin 0.15% cream 5 gram | Is pack of | False | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Warticon 0.15% cream (DE Pharmaceuticals) | Is a | True | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier | |
| Podophyllotoxin 0.15% cream 5 gram | Has VMP | True | Product containing precisely podophyllotoxin 1.5 milligram/1 gram conventional release cutaneous cream | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR